Diagnostic and Statistical Manual of Mental Disorders, 5th Ed.: DSM‐5

Sarmiento, Catalina; Lau, Chloe

doi:10.1002/9781118970843.ch198

Cited by 21 publications

(31 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to the DSM-V criteria, ARFID refers to patients who restrict their dietary intake due to concerns regarding the aversive consequences of eating. Further, ARFID must interfere with nutrition or sufficient energy intake and must occur in the absence of any weight or shape concerns or distorted body image [ 27 ].…”

Section: Eating Disordersmentioning

confidence: 99%

Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse

Kuźnicki

Neubauer

2021

JCM

View full text Add to dashboard Cite

Inflammatory bowel disease (IBD) is a chronic and potentially devastating condition of the digestive tract which is exemplified by increasing prevalence worldwide, byzantine pathogenesis with a poorly defined role of the environmental factors, and complex clinical demonstration. As a systemic disease, IBD may progress with a wide spectrum of extraintestinal manifestations (EMs) and comorbidities affecting different organs and systems, from anaemia, undernutrition, and cancer to those which are often neglected like anxiety and depression. Evolving IBD epidemiology and changing environment are reflected by an expanding list of IBD-related comorbidities. In contrast to the well-established role of smoking the connection between alcohol and IBD is still debatable on many levels, from pathogenesis to complications. Furthermore, little is known about narcotics use in IBD patients, even if there are obvious factors that may predispose them to narcotics as well as alcohol misuse. Last but not least, the question arises what is the prevalence of eating disorders in IBD. In our paper, we aimed to discuss the current knowledge on alcohol and drugs misuse and eating disorders as emerging extraintestinal comorbidities in IBD.

show abstract

Section: Eating Disordersmentioning

confidence: 99%

Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse

Kuźnicki

Neubauer

2021

JCM

View full text Add to dashboard Cite

show abstract

“…A UTISM spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by social and communication impairments and restricted and stereotyped behaviors [1]. ASD typically appears during early childhood and affects the child's cognitive ability, social emotion, sensory and motor functioning, and social interaction.…”

Section: Introductionmentioning

confidence: 99%

A Multimodal Approach for Identifying Autism Spectrum Disorders in Children

Han

Jiang

Ouyang

et al. 2022

IEEE Trans. Neural Syst. Rehabil. Eng.

View full text Add to dashboard Cite

Identification of autism spectrum disorder (ASD) in children is challenging due to the complexity and heterogeneity of ASD. Currently, most existing methods mainly rely on a single modality with limited information and often cannot achieve satisfactory performance. To address this issue, this paper investigates from internal neurophysiological and external behavior perspectives simultaneously and proposes a new multimodal diagnosis framework for identifying ASD in children with fusion of electroencephalogram (EEG) and eye-tracking (ET) data. Specifically, we designed a two-step multimodal feature learning and fusion model based on a typical deep learning algorithm, stacked denoising autoencoder (SDAE). In the first step, two SDAE models are designed for feature learning for EEG and ET modality, respectively. Then, a third SDAE model in the second step is designed to perform multimodal fusion with learned EEG and ET features in a concatenated way. Our designed multimodal identification model can automatically capture correlations and complementarity from behavior modality and neurophysiological modality in a latent feature space, and generate informative feature representations with better discriminability and generalization for enhanced identification performance. We collected a multimodal dataset containing 40 ASD children and 50 typically developing (TD) children to evaluate our proposed method. Experimental results showed that our proposed method achieved superior performance compared with two unimodal methods and a simple feature-level fusion method, which has promising potential to provide an objective and accurate diagnosis to assist clinicians.

show abstract

“…17 For example, it does not contain questions about appetite changes or fatigue, although both are part of the criteria of depression in the DSM. 16 The HADS was previously validated for IBD patients in Mexico 18 and Canada 19 and used in other studies for assessment of anxiety and depression among IBD patients. 8,20,21 The aim of this study was to establish the utility of the Hebrew version of the HADS as a screening tool in Israeli IBD patients, by comparing its scores with wildly accepted and used depression and anxiety questionnaires: the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI).…”

Section: Introductionmentioning

confidence: 99%

“…As there are no relevant laboratory or imaging techniques, the diagnosis of depression or anxiety is based solely on anamnesis, and according to the criteria of the Diagnostic and Statistical Manual (DSM) of the America Psychiatric Association. 16 This causes two major caveats: First, the diagnosis is influenced by the subjectivity of the patient and the doctor. Second, the diagnoses are dichotomous, meaning a patient will be classified as either being depressed/anxious or not, which is an over-simplification of the human condition.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel

Avinir

Dar

Taler

et al. 2022

Therap Adv Gastroenterol

View full text Add to dashboard Cite

Background: Depression and anxiety are common among inflammatory bowel disease (IBD) patients. Not only do they worsen quality of life, but also worsen the prognosis of the IBD. Yet, there are no widely accepted guidelines for screening for depression or anxiety in this population. The Hospital Anxiety and Depression Scale (HADS) is a self-administered questionnaire designed to measure anxiety and depression in the physically ill. The purpose of this study was to establish the utility of the HADS as a screening tool in IBD patients. Methods: Seventy-nine IBD patients (age 29.86 ± 8.36, 51.9% female, 77.2% Crohn’s disease) were recruited consecutively at the day treatment unit, Gastroenterology Department, Sheba Medical Center. They were asked to complete the HADS, the Beck Depression Inventory (BDI), and the State-Trait Anxiety Inventory (STAI). The scores of the HADS depression and anxiety subscales were correlated with the BDI and STAI scores, and the rates of above-threshold scores were calculated and compared between the three questionnaires and findings from previous studies. Results: The two HADS subscales significantly correlated with and the BDI ( rs = .69, p < 0.001) and STAI state and trait anxiety ( rs = .853, p < 0.001; rs = .744, p < 0.001, respectively). The usual HADS cut-off scores yielded adequate rate of anxiety but lower than expected depression rates. Conclusions: Our findings suggest the HADS as a valid screening tool for anxiety and depression in IBD patients. We recommend administering it routinely in gastrointestinal (GI) follow-ups using a lower cut-off score for depression than anxiety (greater than 7 vs greater than 11, respectively).

show abstract

Diagnostic and Statistical Manual of Mental Disorders, 5th Ed.: DSM‐5

Cited by 21 publications

References 7 publications

Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse

Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse

A Multimodal Approach for Identifying Autism Spectrum Disorders in Children

Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel

Contact Info

Product

Resources

About